{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:26:30Z","timestamp":1779330390381,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82150117"],"award-info":[{"award-number":["82150117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82101329"],"award-info":[{"award-number":["82101329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071745"],"award-info":[{"award-number":["82071745"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2020YFA0509400"],"award-info":[{"award-number":["2020YFA0509400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s13402-024-00959-1","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T12:01:29Z","timestamp":1716984089000},"page":"1779-1796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function"],"prefix":"10.1007","volume":"47","author":[{"given":"Yujia","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiumei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunliu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengzhou","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congzhou","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongrui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,29]]},"reference":[{"key":"959_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","volume":"21","author":"A.E. Whiteley","year":"2021","unstructured":"A.E. Whiteley, T.T. Price, G. Cantelli, D.A. Sipkins, Leukaemia: a model metastatic disease. Nat. Rev. Cancer 21, 461\u2013475 (2021)","journal-title":"Nat. Rev. Cancer"},{"key":"959_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s12098-015-1695-5","volume":"82","author":"R. Seth","year":"2015","unstructured":"R. Seth, A. Singh, Leukemias in children. Indian J. Pediatr. 82, 817\u2013824 (2015)","journal-title":"Indian J. Pediatr."},{"key":"959_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H. Sung","year":"2021","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021)","journal-title":"CA Cancer J. Clin."},{"key":"959_CR4","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F. Malard","year":"2020","unstructured":"F. Malard, M. Mohty, Acute lymphoblastic leukaemia. Lancet 395, 1146\u20131162 (2020)","journal-title":"Lancet"},{"key":"959_CR5","doi-asserted-by":"crossref","unstructured":"Stat bite: estimated new leukemia cases in 2008. J. Natl. Cancer Inst. 100, 531 (2008)","DOI":"10.1093\/jnci\/djn111"},{"key":"959_CR6","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","volume":"30","author":"S.P. Hunger","year":"2012","unstructured":"S.P. Hunger, X. Lu, M. Devidas, B.M. Camitta, P.S. Gaynon, N.J. Winick, G.H. Reaman, W.L. Carroll, Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children\u2019s oncology group. J. Clin. Oncol. 30, 1663\u20131669 (2012)","journal-title":"J. Clin. Oncol."},{"key":"959_CR7","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood-2008-06-164863","volume":"113","author":"D. Pulte","year":"2009","unstructured":"D. Pulte, A. Gondos, H. Brenner, Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 113, 1408\u20131411 (2009)","journal-title":"Blood"},{"key":"959_CR8","doi-asserted-by":"publisher","first-page":"e85554","DOI":"10.1371\/journal.pone.0085554","volume":"9","author":"D. Pulte","year":"2014","unstructured":"D. Pulte, L. Jansen, A. Gondos, A. Katalinic, B. Barnes, M. Ressing, B. Holleczek, A. Eberle, H. Brenner, G.C.S.W. Group, Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLoS One 9, e85554 (2014)","journal-title":"PLoS One"},{"key":"959_CR9","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","volume":"360","author":"C.H. Pui","year":"2009","unstructured":"C.H. Pui, D. Campana, D. Pei, W.P. Bowman, J.T. Sandlund, S.C. Kaste, R.C. Ribeiro, J.E. Rubnitz, S.C. Raimondi, M. Onciu, E. Coustan-Smith, L.E. Kun, S. Jeha, C. Cheng, S.C. Howard, V. Simmons, A. Bayles, M.L. Metzger, J.M. Boyett, W. Leung, R. Handgretinger, J.R. Downing, W.E. Evans, M.V. Relling, Treating childhood acute lymphoblastic leukemia without cranial irradiation. N. Engl. J. Med. 360, 2730\u20132741 (2009)","journal-title":"N. Engl. J. Med."},{"key":"959_CR10","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2174\/138920012800840400","volume":"13","author":"T.A. de Beaumais","year":"2012","unstructured":"T.A. de Beaumais, E. Jacqz-Aigrain, Intracellular disposition of methotrexate in acute lymphoblastic leukemia in children. Curr. Drug. Metab. 13, 822\u2013834 (2012)","journal-title":"Curr. Drug. Metab."},{"key":"959_CR11","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","volume":"106","author":"J.M. Rowe","year":"2005","unstructured":"J.M. Rowe, G. Buck, A.K. Burnett, R. Chopra, P.H. Wiernik, S.M. Richards, H.M. Lazarus, I.M. Franklin, M.R. Litzow, N. Ciobanu, H.G. Prentice, J. Durrant, M.S. Tallman, A.H. Goldstone, Ecog, M.N.A.L.W. Party, Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993. Blood 106, 3760\u20133767 (2005)","journal-title":"Blood"},{"key":"959_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1182\/blood-2015-07-604546","volume":"127","author":"J.J. Cornelissen","year":"2016","unstructured":"J.J. Cornelissen, D. Blaise, Hematopoietic stem cell transplantation for patients with AML in first complete remission. Blood 127, 62\u201370 (2016)","journal-title":"Blood"},{"key":"959_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/bmt.2016.283","volume":"52","author":"Y.R. Ma","year":"2017","unstructured":"Y.R. Ma, L.P. Xu, X.H. Zhang, C.H. Yan, Y. Wang, F.R. Wang, J.Z. Wang, Y. Chen, W. Han, Y.H. Chen, H. Chen, K.Y. Liu, X.J. Huang, Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation. Bone Marrow Transplant. 52, 409\u2013414 (2017)","journal-title":"Bone Marrow Transplant."},{"key":"959_CR14","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood-2006-03-011908","volume":"109","author":"A. de Labarthe","year":"2007","unstructured":"A. de Labarthe, P. Rousselot, F. Huguet-Rigal, E. Delabesse, F. Witz, S. Maury, D. Rea, J.M. Cayuela, M.C. Vekemans, O. Reman, A. Buzyn, A. Pigneux, M. Escoffre, Y. Chalandon, E. MacIntyre, V. Lheritier, J.P. Vernant, X. Thomas, N. Ifrah, H. Dombret, L. Group for Research on Adult Acute Lymphoblastic, Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. Blood 109, 1408\u20131413 (2007)","journal-title":"Blood"},{"key":"959_CR15","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1002\/cncr.29646","volume":"121","author":"F. Ravandi","year":"2015","unstructured":"F. Ravandi, S.M. O\u2019Brien, J.E. Cortes, D.M. Thomas, R. Garris, S. Faderl, J.A. Burger, M.E. Rytting, A. Ferrajoli, W.G. Wierda, S. Verstovsek, R. Champlin, P. Kebriaei, D.A. McCue, X. Huang, E. Jabbour, G. Garcia-Manero, Z. Estrov, H.M. Kantarjian, Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 121, 4158\u20134164 (2015)","journal-title":"Cancer"},{"key":"959_CR16","doi-asserted-by":"publisher","first-page":"177ra138","DOI":"10.1126\/scitranslmed.3005930","volume":"5","author":"R.J. Brentjens","year":"2013","unstructured":"R.J. Brentjens, M.L. Davila, I. Riviere, J. Park, X. Wang, L.G. Cowell, S. Bartido, J. Stefanski, C. Taylor, M. Olszewska, O. Borquez-ojeda, J. Qu, T. Wasielewska, Q. He, Y. Bernal, I.V. Rijo, C. Hedvat, R. Kobos, K. Curran, P. Steinherz, J. Jurcic, T. Rosenblat, P. Maslak, M. Frattini, M. Sadelain, CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci. Transl. Med. 5, 177ra138 (2013)","journal-title":"Sci. Transl. Med."},{"key":"959_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1056\/NEJMoa2024850","volume":"384","author":"N.C. Munshi","year":"2021","unstructured":"N.C. Munshi, L.D. Anderson Jr., N. Shah, D. Madduri, J. Berdeja, S. Lonial, N. Raje, Y. Lin, D. Siegel, A. Oriol, P. Moreau, I. Yakoub-Agha, M. Delforge, M. Cavo, H. Einsele, H. Goldschmidt, K. Weisel, A. Rambaldi, D. Reece, F. Petrocca, M. Massaro, J.N. Connarn, S. Kaiser, P. Patel, L. Huang, T.B. Campbell, K. Hege, J. San-Miguel, Idecabtagene vicleucel in relapsed and refractory multiple myeloma. N. Engl. J. Med. 384, 705\u2013716 (2021)","journal-title":"N. Engl. J. Med."},{"key":"959_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"R.C. Sterner","year":"2021","unstructured":"R.C. Sterner, R.M. Sterner, CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021)","journal-title":"Blood Cancer J."},{"key":"959_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa1709919","volume":"378","author":"J.H. Park","year":"2018","unstructured":"J.H. Park, I. Riviere, M. Gonen, X. Wang, B. Senechal, K.J. Curran, C. Sauter, Y. Wang, B. Santomasso, E. Mead, M. Roshal, P. Maslak, M. Davila, R.J. Brentjens, M. Sadelain, Long-term follow-up of CD19 CAR therapy in acute lymphoblastic. Leukemia N. Engl. J. Med. 378, 449\u2013459 (2018)","journal-title":"Leukemia N. Engl. J. Med."},{"key":"959_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"S.L. Maude","year":"2018","unstructured":"S.L. Maude, T.W. Laetsch, J. Buechner, S. Rives, M. Boyer, H. Bittencourt, P. Bader, M.R. Verneris, H.E. Stefanski, G.D. Myers, M. Qayed, B. De Moerloose, H. Hiramatsu, K. Schlis, K.L. Davis, P.L. Martin, E.R. Nemecek, G.A. Yanik, C. Peters, A. Baruchel, N. Boissel, F. Mechinaud, A. Balduzzi, J. Krueger, C.H. June, B.L. Levine, P. Wood, T. Taran, M. Leung, K.T. Mueller, Y. Zhang, K. Sen, D. Lebwohl, M.A. Pulsipher, S.A. Grupp, Tisagenlecleucel in children and young adults with B-cell lymphoblastic Leukemia. N. Engl. J. Med. 378, 439\u2013448 (2018)","journal-title":"N. Engl. J. Med."},{"key":"959_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s13402-022-00700-w","volume":"45","author":"A. Bozorgi","year":"2022","unstructured":"A. Bozorgi, M. Bozorgi, M. Khazaei, Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects. Cell Oncol. Dordr. 45, 755\u2013777 (2022)","journal-title":"Cell Oncol. Dordr."},{"key":"959_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s13402-021-00593-1","volume":"44","author":"M. Akhoundi","year":"2021","unstructured":"M. Akhoundi, M. Mohammadi, S.S. Sahraei, M. Sheykhhasan, N. Fayazi, CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities. Cell Oncol. Dordr. 44, 495\u2013523 (2021)","journal-title":"Cell Oncol. Dordr."},{"key":"959_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nri1917","volume":"6","author":"K.M. Murphy","year":"2006","unstructured":"K.M. Murphy, C.A. Nelson, J.R. Sedy, Balancing co-stimulation and inhibition with BTLA and HVEM. Nat. Rev. Immunol. 6, 671\u2013681 (2006)","journal-title":"Nat. Rev. Immunol."},{"key":"959_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41423-019-0241-1","volume":"16","author":"J.I. Rodriguez-Barbosa","year":"2019","unstructured":"J.I. Rodriguez-Barbosa, P. Schneider, A. Weigert, K.M. Lee, T.J. Kim, J.A. Perez-Simon, M.L. Del Rio, HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT. Cell Mol. Immunol. 16, 679\u2013682 (2019)","journal-title":"Cell Mol. Immunol."},{"key":"959_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev-immunol-030409-101202","volume":"28","author":"T.L. Murphy","year":"2010","unstructured":"T.L. Murphy, K.M. Murphy, Slow down and survive: enigmatic immunoregulation by BTLA and HVEM. Annu. Rev. Immunol. 28, 389\u2013411 (2010)","journal-title":"Annu. Rev. Immunol."},{"key":"959_CR26","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ni944","volume":"4","author":"N. Watanabe","year":"2003","unstructured":"N. Watanabe, M. Gavrieli, J.R. Sedy, J. Yang, F. Fallarino, S.K. Loftin, M.A. Hurchla, N. Zimmerman, J. Sim, X. Zang, T.L. Murphy, J.H. Russell, J.P. Allison, K.M. Murphy, BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4, 670\u2013679 (2003)","journal-title":"Nat. Immunol."},{"key":"959_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1073\/pnas.0409071102","volume":"102","author":"L.C. Gonzalez","year":"2005","unstructured":"L.C. Gonzalez, K.M. Loyet, J. Calemine-Fenaux, V. Chauhan, B. Wranik, W. Ouyang, D.L. Eaton, A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc. Natl. Acad. Sci. U. S. A. 102, 1116\u20131121 (2005)","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"959_CR28","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1002\/eji.200425598","volume":"34","author":"T. Duhen","year":"2004","unstructured":"T. Duhen, C. Pasero, F. Mallet, B. Barbarat, D. Olive, R.T. Costello, LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation. Eur. J. Immunol. 34, 3534\u20133541 (2004)","journal-title":"Eur. J. Immunol."},{"key":"959_CR29","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.4049\/jimmunol.167.5.2479","volume":"167","author":"Y. Morel","year":"2001","unstructured":"Y. Morel, A. Truneh, R.W. Sweet, D. Olive, R.T. Costello, The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J. Immunol. 167, 2479\u20132486 (2001)","journal-title":"J. Immunol."},{"key":"959_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1074-7613(00)80455-0","volume":"8","author":"D.N. Mauri","year":"1998","unstructured":"D.N. Mauri, R. Ebner, R.I. Montgomery, K.D. Kochel, T.C. Cheung, G.L. Yu, S. Ruben, M. Murphy, R.J. Eisenberg, G.H. Cohen, P.G. Spear, C.F. Ware, LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8, 21\u201330 (1998)","journal-title":"Immunity"},{"key":"959_CR31","doi-asserted-by":"crossref","unstructured":"R.J. Schilder, J.D. Powderly, H. Park, M.A. Bilen, M. McKean, R. May, H. Feng, S. Yao, P. Keegan, A. Naing, Phase Ia dose-escalation study of the anti-BTLA antibody icatolimab as a monotherapy in patients with advanced solid tumor. J. Clin. Oncol. 40 (2022)","DOI":"10.1200\/JCO.2022.40.16_suppl.2643"},{"key":"959_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1200\/JCO.22.00727","volume":"41","author":"Z. Wang","year":"2023","unstructured":"Z. Wang, L. Wu, B. Li, Y. Cheng, X. Li, X. Wang, L. Han, X. Wu, Y. Fan, Y. Yu, D. Lv, J. Shi, J. Huang, S. Zhou, B. Han, G. Sun, Q. Guo, Y. Ji, X. Zhu, S. Hu, W. Zhang, Q. Wang, Y. Jia, Z. Wang, Y. Song, J. Wu, M. Shi, X. Li, Z. Han, Y. Liu, Z. Yu, A.W. Liu, X. Wang, C. Zhou, D. Zhong, L. Miao, Z. Zhang, H. Zhao, J. Yang, D. Wang, Y. Wang, Q. Li, X. Zhang, M. Ji, Z. Yang, J. Cui, B. Gao, B. Wang, H. Liu, L. Nie, M. He, S. Jin, W. Gu, Y. Shu, T. Zhou, J. Feng, X. Yang, C. Huang, B. Zhu, Y. Yao, X. Tang, J. Yu, E. Maher, H. Feng, S. Yao, P. Keegan, J. Wang, Toripalimab plus chemotherapy for patients with treatment-naive advanced non-small-cell lung cancer: a multicenter randomized phase III trial (CHOICE-01). J. Clin. Oncol. 41, 651\u2013663 (2023)","journal-title":"J. Clin. Oncol."},{"key":"959_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1462-5822.2004.00389.x","volume":"6","author":"P.G. Spear","year":"2004","unstructured":"P.G. Spear, Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol. 6, 401\u2013410 (2004)","journal-title":"Cell Microbiol."},{"key":"959_CR34","doi-asserted-by":"publisher","first-page":"e1665976","DOI":"10.1080\/2162402X.2019.1665976","volume":"8","author":"N. Malissen","year":"2019","unstructured":"N. Malissen, N. Macagno, S. Granjeaud, C. Granier, V. Moutardier, C. Gaudy-Marqueste, N. Habel, M. Mandavit, B. Guillot, C. Pasero, E. Tartour, R. Ballotti, J.J. Grob, D. Olive, HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma. Oncoimmunology 8, e1665976 (2019)","journal-title":"Oncoimmunology"},{"key":"959_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ebiom.2019.04.002","volume":"43","author":"M.Z. Han","year":"2019","unstructured":"M.Z. Han, S. Wang, W.B. Zhao, S.L. Ni, N. Yang, Y. Kong, B. Huang, A.J. Chen, X.G. Li, J. Wang, D.H. Wang, Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma. EBioMed. 43, 159\u2013170 (2019)","journal-title":"EBioMed."},{"key":"959_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejca.2014.11.004","volume":"51","author":"D. Hokuto","year":"2015","unstructured":"D. Hokuto, M. Sho, I. Yamato, S. Yasuda, S. Obara, T. Nomi, Y. Nakajima, Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma. Eur. J. Cancer 51, 157\u2013165 (2015)","journal-title":"Eur. J. Cancer"},{"key":"959_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.19003","volume":"59","author":"J. Carreras","year":"2019","unstructured":"J. Carreras, A. Lopez-Guillermo, Y.Y. Kikuti, J. Itoh, M. Masashi, H. Ikoma, S. Tomita, S. Hiraiwa, R. Hamoudi, A. Rosenwald, E. Leich, A. Martinez, G. Roncador, N. Villamor, L. Colomo, P. Perez, N.M. Tsuji, E. Campo, N. Nakamura, High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in diffuse large B-cell Lymphoma transformation. J. Clin. Exp. Hematop. 59, 1\u201316 (2019)","journal-title":"J. Clin. Exp. Hematop."},{"key":"959_CR38","doi-asserted-by":"crossref","unstructured":"C. Sordo-Bahamonde, S. Lorenzo-Herrero, A.P. Gonzalez-Rodriguez, A.R. Payer, E. Gonzalez-Garcia, A. Lopez-Soto, S. Gonzalez, BTLA\/HVEM axis induces NK cell immunosuppression and poor outcome in chronic lymphocytic leukemia. Cancers (Basel) 13 (2021)","DOI":"10.3390\/cancers13081766"},{"key":"959_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cell.2016.08.032","volume":"167","author":"M. Boice","year":"2016","unstructured":"M. Boice, D. Salloum, F. Mourcin, V. Sanghvi, R. Amin, E. Oricchio, M. Jiang, A. Mottok, N. Denis-Lagache, G. Ciriello, W. Tam, J. Teruya-Feldstein, E. de Stanchina, W.C. Chan, S.N. Malek, D. Ennishi, R.J. Brentjens, R.D. Gascoyne, M. Cogne, K. Tarte, H.G. Wendel, Loss of the HVEM tumor suppressor in Lymphoma and restoration by modified CAR-T cells. Cell 167, 405\u2013418 e413 (2016)","journal-title":"Cell"},{"key":"959_CR40","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/JLB.5MA0421-013R","volume":"110","author":"C. Zhong","year":"2021","unstructured":"C. Zhong, L. Wang, S. Hu, C. Huang, Z. Xia, J. Liao, W. Yi, J. Chen, Poly(I:C) enhances the efficacy of phagocytosis checkpoint blockade immunotherapy by inducing IL-6 production. J. Leukoc. Biol. 110, 1197\u20131208 (2021)","journal-title":"J. Leukoc. Biol."},{"key":"959_CR41","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s13402-023-00794-w","volume":"46","author":"Y.Y. Li","year":"2023","unstructured":"Y.Y. Li, X.Y. Wang, Y. Li, X.M. Wang, J. Liao, Y.Z. Wang, H. Hong, W. Yi, J. Chen, Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer. Cell Oncol. Dordr. 46, 777\u2013791 (2023)","journal-title":"Cell Oncol. Dordr."},{"key":"959_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s43018-023-00691-z","volume":"5","author":"C. Huang","year":"2024","unstructured":"C. Huang, X. Wang, Y. Wang, Y. Feng, X. Wang, S. Chen, P. Yan, J. Liao, Q. Zhang, C. Mao, Y. Li, L. Wang, X. Wang, W. Yi, W. Cai, S. Chen, N. Hong, W. He, J. Chen, W. Jin, Sirpalpha on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47. Nat. Cancer 5, 500\u2013516 (2024)","journal-title":"Nat. Cancer"},{"key":"959_CR43","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","volume":"4","author":"Y. Mei","year":"2023","unstructured":"Y. Mei, X. Wang, J. Zhang, D. Liu, J. He, C. Huang, J. Liao, Y. Wang, Y. Feng, H. Li, X. Liu, L. Chen, W. Yi, X. Chen, H.M. Bai, X. Wang, Y. Li, L. Wang, Z. Liang, X. Ren, L. Qiu, Y. Hui, Q. Zhang, Q. Leng, J. Chen, G. Jia, Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. Nat. Cancer 4, 1273\u20131291 (2023)","journal-title":"Nat. Cancer"},{"key":"959_CR44","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"M.J. Goldman","year":"2020","unstructured":"M.J. Goldman, B. Craft, M. Hastie, K. Repecka, F. McDade, A. Kamath, A. Banerjee, Y. Luo, D. Rogers, A.N. Brooks, J. Zhu, D. Haussler, Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. 38, 675\u2013678 (2020)","journal-title":"Nat. Biotechnol."},{"key":"959_CR45","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D. Kim","year":"2019","unstructured":"D. Kim, J.M. Paggi, C. Park, C. Bennett, S.L. Salzberg, Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019)","journal-title":"Nat. Biotechnol."},{"key":"959_CR46","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"M.I. Love","year":"2014","unstructured":"M.I. Love, W. Huber, S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014)","journal-title":"Genome Biol."},{"key":"959_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M. Ashburner","year":"2000","unstructured":"M. Ashburner, C.A. Ball, J.A. Blake, D. Botstein, H. Butler, J.M. Cherry, A.P. Davis, K. Dolinski, S.S. Dwight, J.T. Eppig, M.A. Harris, D.P. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J.C. Matese, J.E. Richardson, M. Ringwald, G.M. Rubin, G. Sherlock, Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25, 25\u201329 (2000)","journal-title":"Nat. Genet."},{"key":"959_CR48","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"D.A. Barbie","year":"2009","unstructured":"D.A. Barbie, P. Tamayo, J.S. Boehm, S.Y. Kim, S.E. Moody, I.F. Dunn, A.C. Schinzel, P. Sandy, E. Meylan, C. Scholl, S. Frohling, E.M. Chan, M.L. Sos, K. Michel, C. Mermel, S.J. Silver, B.A. Weir, J.H. Reiling, Q. Sheng, P.B. Gupta, R.C. Wadlow, H. Le, S. Hoersch, B.S. Wittner, S. Ramaswamy, D.M. Livingston, D.M. Sabatini, M. Meyerson, R.K. Thomas, E.S. Lander, J.P. Mesirov, D.E. Root, D.G. Gilliland, T. Jacks, W.C. Hahn, Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009)","journal-title":"Nature"},{"key":"959_CR49","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z. Tang","year":"2017","unstructured":"Z. Tang, C. Li, B. Kang, G. Gao, C. Li, Z. Zhang, GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98\u2013W102 (2017)","journal-title":"Nucleic Acids Res."},{"key":"959_CR50","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","volume":"317","author":"J.R. Groom","year":"2011","unstructured":"J.R. Groom, A.D. Luster, CXCR3 in T cell function. Exp. Cell Res. 317, 620\u2013631 (2011)","journal-title":"Exp. Cell Res."},{"key":"959_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0092-8674(94)90372-7","volume":"76","author":"C.A. Smith","year":"1994","unstructured":"C.A. Smith, T. Farrah, R.G. Goodwin, The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959\u2013962 (1994)","journal-title":"Cell"},{"key":"959_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ni1144","volume":"6","author":"J.R. Sedy","year":"2005","unstructured":"J.R. Sedy, M. Gavrieli, K.G. Potter, M.A. Hurchla, R.C. Lindsley, K. Hildner, S. Scheu, K. Pfeffer, C.F. Ware, T.L. Murphy, K.M. Murphy, B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6, 90\u201398 (2005)","journal-title":"Nat. Immunol."},{"key":"959_CR53","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrc2607","volume":"9","author":"J.L. Nitiss","year":"2009","unstructured":"J.L. Nitiss, Targeting DNA topoisomerase II in cancer chemotherapy. Nat. Rev. Cancer 9, 338\u2013350 (2009)","journal-title":"Nat. Rev. Cancer"},{"key":"959_CR54","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"J.D. Fontenot","year":"2003","unstructured":"J.D. Fontenot, M.A. Gavin, A.Y. Rudensky, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330\u2013336 (2003)","journal-title":"Nat. Immunol."},{"key":"959_CR55","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ni1554","volume":"9","author":"G. Cai","year":"2008","unstructured":"G. Cai, A. Anumanthan, J.A. Brown, E.A. Greenfield, B. Zhu, G.J. Freeman, CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat. Immunol. 9, 176\u2013185 (2008)","journal-title":"Nat. Immunol."},{"key":"959_CR56","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-065X.2009.00783.x","volume":"229","author":"G. Cai","year":"2009","unstructured":"G. Cai, G.J. Freeman, The CD160, BTLA, LIGHT\/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol. Rev. 229, 244\u2013258 (2009)","journal-title":"Immunol. Rev."},{"key":"959_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.imlet.2006.04.006","volume":"106","author":"K. Tsujimura","year":"2006","unstructured":"K. Tsujimura, Y. Obata, Y. Matsudaira, K. Nishida, Y. Akatsuka, Y. Ito, A. Demachi-Okamura, K. Kuzushima, T. Takahashi, Characterization of murine CD160+ CD8+ T lymphocytes. Immunol. Lett. 106, 48\u201356 (2006)","journal-title":"Immunol. Lett."},{"key":"959_CR58","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.4049\/jimmunol.174.6.3377","volume":"174","author":"M.A. Hurchla","year":"2005","unstructured":"M.A. Hurchla, J.R. Sedy, M. Gavrieli, C.G. Drake, T.L. Murphy, K.M. Murphy, B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells. J. Immunol. 174, 3377\u20133385 (2005)","journal-title":"J. Immunol."},{"key":"959_CR59","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","volume":"175","author":"M.F. Sanmamed","year":"2018","unstructured":"M.F. Sanmamed, L. Chen, A paradigm shift in cancer immunotherapy: from enhancement to normalization. Cell 175, 313\u2013326 (2018)","journal-title":"Cell"},{"key":"959_CR60","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.4049\/jimmunol.178.10.6073","volume":"178","author":"M.A. Hurchla","year":"2007","unstructured":"M.A. Hurchla, J.R. Sedy, K.M. Murphy, Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation. J. Immunol. 178, 6073\u20136082 (2007)","journal-title":"J. Immunol."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-00959-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-024-00959-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-00959-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T16:12:16Z","timestamp":1728576736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-024-00959-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["959"],"URL":"https:\/\/doi.org\/10.1007\/s13402-024-00959-1","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,29]]},"assertion":[{"value":"11 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed with the approval of the Institutional Animal Care and Use Committee, Sun Yat-Sen University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have declared no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}